On 28 March 2017, Van Bael & Bellis was named Regional Firm of the Year – Europe at the GCR 7th Annual Awards ceremony held in Washington, DC. The awards are organised by Global Competition Review (GCR), the world’s leading antitrust and competition law journal and news service.
On May 18 2017, Thibaut D’hulst spoke at Europe's leading pharmaceutical law conference held in Brussels. Thibaut’s presentation focused on transparency and collaborations between industry and healthcare institutions and payments to healthcare professionals.
The Court of Justice of the European Union (“CJEU”) delivered on 16 May 2017 its long-awaited Opinion 2/15 on the allocation of competences between the European Union and the Member States as regards the Free Trade Agreement between the European Union and the Republic of Singapore (the “EUSFTA”), which is one of the first “new generation” trade agreements.
Life Sciences | The European Commission (the “Commission”) announced on 15 May 2017 that it has opened formal competition proceedings against Aspen Pharma (“Aspen”) over concerns that Aspen indulged in excessive pricing when commercialising its portfolio of 5 cancer medicines which it had acquired from GlaxoSmithKline after the patents in the active substances had expired (see attached press release).